- Home
- FROG vs BHVN Comparison
FROG vs BHVN Comparison
Compare FROG & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FROG
- BHVN
- Stock Information
- Founded
- FROG 2008
- BHVN 2013
- Country
- FROG United States
- BHVN United States
- Employees
- FROG N/A
- BHVN N/A
- Industry
- FROG Computer Software: Prepackaged Software
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- FROG Technology
- BHVN Health Care
- Exchange
- FROG Nasdaq
- BHVN Nasdaq
- Market Cap
- FROG 3.7B
- BHVN 3.6B
- IPO Year
- FROG 2020
- BHVN 2017
- Fundamental
- Price
- FROG $33.92
- BHVN $39.01
- Analyst Decision
- FROG Strong Buy
- BHVN Strong Buy
- Analyst Count
- FROG 18
- BHVN 13
- Target Price
- FROG $36.65
- BHVN $63.00
- AVG Volume (30 Days)
- FROG 870.1K
- BHVN 1.2M
- Earning Date
- FROG 02-13-2025
- BHVN 02-27-2025
- Dividend Yield
- FROG N/A
- BHVN N/A
- EPS Growth
- FROG N/A
- BHVN N/A
- EPS
- FROG N/A
- BHVN N/A
- Revenue
- FROG $409,670,000.00
- BHVN N/A
- Revenue This Year
- FROG $24.37
- BHVN N/A
- Revenue Next Year
- FROG $17.11
- BHVN $197.13
- P/E Ratio
- FROG N/A
- BHVN N/A
- Revenue Growth
- FROG 24.45
- BHVN N/A
- 52 Week Low
- FROG $22.91
- BHVN $26.80
- 52 Week High
- FROG $48.81
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- FROG 67.48
- BHVN 50.83
- Support Level
- FROG $30.67
- BHVN $35.01
- Resistance Level
- FROG $34.05
- BHVN $40.46
- Average True Range (ATR)
- FROG 1.18
- BHVN 2.15
- MACD
- FROG 0.32
- BHVN 0.41
- Stochastic Oscillator
- FROG 91.74
- BHVN 76.87
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.